BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28

• Drug Development

  Optimer Pharmaceuticals, Inc.'s Lead Antibiotic Candidate Moves Into Phase 2B/3 Clinical Trials For The Treatment Of Clostridium Difficile-Associated Diarrhea (CDAD)

  February 7, 2006

   · 

  3 min read
• Policy

  Emisphere Technologies, Inc. Responds To Eli Lilly and Company Motion

  February 7, 2006

   · 

  3 min read
• Business

  Vasogen To Conduct Year-End Conference Call

  February 7, 2006

   · 

  3 min read
• Business

  Array BioPharma, Inc. Reports Financial Results For The Second Quarter Of Fiscal 2006

  February 7, 2006

   · 

  7 min read
• AEterna Zentaris To Present At Upcoming Biotechnology Industry Organization (BIO) CEO & Investor Conference In New York City

  February 7, 2006

   · 

  1 min read
• Business

  Vical Incorporated Announces News Release And Conference Call Schedule For 2005 Financial Results

  February 7, 2006

   · 

  3 min read
• Business

  Carmie Mehrlander Named Executive Director Of Thanks And Giving For St. Jude Children’s Research Hospital

  February 7, 2006

   · 

  2 min read
• Business

  Aphton Corporation To Expand Licensing And Commercialization Agreements Into Europe For IGN311

  February 7, 2006

   · 

  1 min read
• BioMidwest

  Eli Lilly and Company Launches Humalog(R) Mix50/50(TM) Insulin In United States

  February 7, 2006

   · 

  3 min read
• Business

  Idenix Pharmaceuticals, Inc. And Novartis Corporation Seek European Approval Of Telbivudine For The Treatment Of Patients With Chronic Hepatitis B

  February 7, 2006

   · 

  7 min read